Navigation Links
MIT aids creation of neural prosthetic devices
Date:10/3/2007

CAMBRIDGE, Mass.--MIT researchers have developed a new algorithm to help create prosthetic devices that convert brain signals into action in patients who have been paralyzed or had limbs amputated.

The technique, described in a paper published as the cover article in the October edition of the Journal of Neurophysiology, unifies seemingly disparate approaches taken by experimental groups that prototype these neural prosthetic devices in animals or humans.

The work represents an important advance in our understanding of how to construct algorithms in neural prosthetic devices for people who cannot move to act or speak, said Lakshminarayan Ram Srinivasan (MIT S.M., Ph.D. '06), lead author of the paper.

Srinivasan, currently a postdoctoral researcher at the Center for Nervous System Repair at Massachusetts General Hospital and a medical student in the Harvard-MIT Division of Health Sciences and Technology (HST), began working on the algorithm while a graduate student in MIT's Department of Electrical Engineering and Computer Science (EECS).

Both trauma and disease can lead to paralysis or amputation, reducing the ability to move or talk despite the capacity to think and form intentions. In spinal cord injuries, strokes, and diseases such as amyotrophic lateral sclerosis (Lou Gehrig's disease), the neurons that carry commands from the brain to muscle can be injured. In amputation, both nerves and muscle are lost.

Neural prosthetic devices represent an engineer's approach to treating paralysis and amputation. Here, electronics are used to monitor the neural signals that reflect an individual's intentions for the prosthesis or computer they are trying to use. Algorithms form the link between neural signals that are recorded, and the user's intentions that are decoded to drive the prosthetic device.

Over the past decade, efforts at prototyping these devices have divided along various boundaries related to brain regions, recording modalities, and applications. The MIT technique provides a common framework that underlies all these various efforts.

The research uses a method called graphical models that has been widely applied to problems in computer science like speech-to-text or automated video analysis. The graphical models used by the MIT team are diagrams composed of circles and arrows that represent how neural activity results from a person's intentions for the prosthetic device they are using.

The diagrams represent the mathematical relationship between the person's intentions and the neural manifestation of that intention, whether the intention is measured by an electoencephalography (EEG), intracranial electrode arrays or optical imaging. These signals could come from a number of brain regions, including cortical or subcortical structures.

Until now, researchers working on brain prosthetics have used different algorithms depending on what method they were using to measure brain activity. The new model is applicable no matter what measurement technique is used, according to Srinivasan. We don't need to reinvent a new paradigm for each modality or brain region, he said.

Srinivasan is quick to underscore that many challenges remain in designing neural prosthetic algorithms before they are available for people to use. While the algorithm is unifying, it is not universal: the algorithm consolidates multiple avenues of development in prostheses, but it isn't the final and only approach these researchers expect to see in the years to come. Moreover, energy efficiency and robustness are key considerations for any portable, implantible bio-electronic device.

Through a better quantitative understanding of how the brain normally controls movement and the mechanisms of disease, he hopes these devices could one day allow for a level of dexterity depicted in movies, such as actor Will Smith's mechanical arm in the movie I Robot.

The gap between existing prototypes and that final goal is wide. Translating an algorithm into a fully functioning clinical device will require a great deal of work, but also represents an intriguing road of scientific and engineering development for the years to come.


'/>"/>

Contact: Elizabeth Thomson
thomson@mit.edu
617-258-5402
Massachusetts Institute of Technology
Source:Eurekalert

Related biology news :

1. Molecular steps involved in the creation of gene-silencing microRNAs identified
2. K-State professors discover enzyme responsible for creation of a beetles hard shell
3. Creationism is not science ?making the case for Darwin at UCL
4. Twin molecular scissors link creation of microRNAs with gene-silencing
5. Creation of antibiotic in test tube holds promise for better antibiotics
6. Worlds leading scientists announce creation of Encyclopedia of Life
7. Gene keeps neural cells on correct developmental path
8. Researchers discover stem cell guide that may be key for targeting neural stem cell treatments
9. Gambling monkeys give insight into neural machinery of risk
10. Brain size may depend upon how neural cells are cleaved
11. Defect in gene causes neuralgic amyotrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/13/2017)... 13, 2017  RSA Conference -- RSA, a Dell ... designed to enhance fraud detection and investigation across ... RSA Fraud & Risk Intelligence Suite. The new ... additional insights from internal and external sources as ... their customers from targeted cybercrime attacks. ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Colo. , March 23, 2017  GlobeImmune, Inc. ... agreement for the sale of 12,835,490 shares of its ... NantWorks  ecosystem of companies. In connection with the sale of ... $100,000 in cash and issue to GlobeImmune 200,000 shares, ... stock. "We are pleased to enter ...
(Date:3/23/2017)... New York , March 23, 2017 ... blood plasma products and derivatives market is fragmented due to the presence ... players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, compete ... leader, these three companies, collectively, held more than 76% of this ... ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... up human tissue regeneration from small lab samples to full-size tissues, bones, even ... to establish a vascular system that delivers blood deep into the developing tissue. ...
(Date:3/22/2017)... 2017   iSpecimen ®, the marketplace ... Pathology Service (DPS), a full-service anatomic pathology reference ... United States , has joined a program offered ... (DHIN) to make human biospecimens and associated data ... program, announced in 2015 as a collaboration between iSpecimen ...
Breaking Biology Technology: